Myriad Genetics Inc (MYGN) returns
Myriad Genetics returns over 10 years
$1,000 invested in Myriad Genetics ten years ago was worth $322.99 at the close on October 30, 2026, with dividends reinvested: an average return of -10.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +47.3% | — | $1,473 | -0.9% |
| 3 months | +18.2% | — | $1,182 | +2.1% |
| Year to date | +3.3% | — | $1,033 | +11.7% |
| 1 year | -20.1% | — | $798.74 | +12.4% |
| 3 years | -56.1% | -24.0% | $438.54 | +88.5% |
| 5 years | -79.4% | -27.1% | $206.37 | +76.0% |
| 10 years | -67.7% | -10.7% | $322.99 | +316.6% |
Myriad Genetics return by calendar year
| Year | MYGN | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +3.3% | +11.7% | -8.4% |
| 2025 | -55.1% | +17.7% | -72.9% |
| 2024 | -28.4% | +24.9% | -53.3% |
| 2023 | +31.9% | +26.2% | +5.7% |
| 2022 | -47.4% | -18.2% | -29.3% |
| 2021 | +39.6% | +28.7% | +10.8% |
| 2020 | -27.4% | +18.4% | -45.8% |
| 2019 | -6.3% | +31.2% | -37.6% |
| 2018 | -15.4% | -4.6% | -10.8% |
| 2017 | +106.1% | +21.7% | +84.4% |
| 2016 | -61.4% | +12.0% | -73.4% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: MYGN financials
No forecast, no recommendation. This page describes Myriad Genetics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.